Pinnacle Biotech products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer with branded portfolios in cardiovascular, diabetes, gastroenterology, antibiotics, OTC and nutraceutical segments.
Pinnacle Biotech products in Pakistan
Pinnacle Biotech (Pvt.) Ltd has 20 medicine presentations registered in Pakistan under 9 brands, covering 9 generic medicines. Most of its products are in Anti-infectives, Endocrine & metabolic and CNS & mental health. Its brands with the most registered strengths and packs are Drugab (Pregabalin), Pinethur (Artemether), Rosurot (Rosuvastatin) and Apixion (Apixaban). 20 products have an official DRAP price on MedInfoBase. See all 9 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Private pharmaceutical manufacturer
- Address
- FD-49-A8, FD-50-A8, FD-51-A8, Korangi Creek Industrial Park, Karachi 75190, Pakistan · 75190
- Website
- pinnacle-biotech.com ↗
- Phone
- +92 21 38899000
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Pinnacle Biotech (Pvt.) Ltd. is priced against the market
15 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Apixion | Apixaban | 5 mg | Tablet | 30's | 114650 | PKR 3,567.94 | PKR 118.93/tablet | 🔒 Pharma Pro |
| Apixion | Apixaban | 2.5 mg | Tablet | 30's | 114651 | PKR 3,356.29 | PKR 111.88/tablet | 🔒 Pharma Pro |
| Consista Tablet 10mgRegistry verified | Tadalafil | — | — | — | 135114Official source ↗ | No indexed price | — | — |
| Consista Tablet 20mgRegistry verified | Tadalafil | — | — | — | 135118Official source ↗ | No indexed price | — | — |
| Consista Tablet 5mgRegistry verified | Tadalafil | — | — | — | 135119Official source ↗ | No indexed price | — | — |
| Dexozac Capsule 30mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets Eq. to Dexlansoprazole | — | — | — | 117995Official source ↗ | No indexed price | — | — |
| Dexozac Capsule 60mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets Eq. to Dexlansoprazole | — | — | — | 117996Official source ↗ | No indexed price | — | — |
| Drugab | Pregabalin | 75 mg | Capsule | 14's | 118050 | PKR 457.11 | PKR 32.65/capsule | 🔒 Pharma Pro |
| Drugab | Pregabalin | 50 mg | Capsule | 14's | 118071 | PKR 444.78 | PKR 31.77/capsule | 🔒 Pharma Pro |
| Drugab | Pregabalin | 100 mg | Capsule | 14's | 118072 | PKR 651.29 | PKR 46.52/capsule | No comparator |
| Empaxo | Empagliflozin | 10 mg | Tablet | 14's | 114524 | PKR 1,151.74 | PKR 82.27/tablet | 🔒 Pharma Pro |
| Empaxo | Empagliflozin | 25 mg | Tablet | 14's | 114525 | PKR 1,378.55 | PKR 98.47/tablet | 🔒 Pharma Pro |
| Empaxo-M | Empagliflozin + Metformin | 12.5 mg + 500 mg | Tablet | 14's | 114347 | PKR 899.04 | PKR 64.22/tablet | 🔒 Pharma Pro |
| Empaxo-M | Empagliflozin + Metformin | 12.5 mg + 1000 mg | Tablet | 14's | 114523 | PKR 1,014.58 | PKR 72.47/tablet | 🔒 Pharma Pro |
| Esozac Capsule 20mgRegistry verified | Enteric Coated Pellets of Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole | — | — | — | 120423Official source ↗ | No indexed price | — | — |
| Esozac Capsules 40mgRegistry verified | Esomeprazole | — | — | — | 123237Official source ↗ | No indexed price | — | — |
| Fibrate Capsule 200mgRegistry verified | Fenofibrate | — | — | — | 137409Official source ↗ | No indexed price | — | — |
| Fibrate Capsule 67mgRegistry verified | Fenofibrate | — | — | — | 137410Official source ↗ | No indexed price | — | — |
| Moxipill | Moxifloxacin | 400 mg | Tablet | 1x5's | 135258 | PKR 475.00 | PKR 95.00/tablet | 🔒 Pharma Pro |
| Naplocip | Ciprofloxacin | 250 mg | Tablet | 10's | 118101 | PKR 268.48 | PKR 26.85/tablet | 🔒 Pharma Pro |
| Naplocip | Ciprofloxacin | 500 mg | Tablet | 10's | 118102 | PKR 444.79 | PKR 44.48/tablet | 🔒 Pharma Pro |
| Pinethur | Artemether | 80 mg + 480 mg | Tablet | 1x8's | 135178 | PKR 330.00 | PKR 41.25/tablet | No comparator |
| Pinethur | Artemether | 40 mg + 240 mg | Tablet | 1x10's | 135179 | PKR 310.00 | PKR 31.00/tablet | No comparator |
| Pinethur | Artemether | 20 mg + 120 mg | Tablet | 2x8's | 137113 | PKR 320.00 | PKR 20.00/tablet | No comparator |
| Pinnaxam Capsule 250mgRegistry verified | Tranexamic acid | — | — | — | 137324Official source ↗ | No indexed price | — | — |
| Pinnaxam Capsule 500mgRegistry verified | Tranexamic acid | — | — | — | 137323Official source ↗ | No indexed price | — | — |
| Que Tablet 100mgRegistry verified | Quetiapine Fumarate Eq. to Quetiapine | — | — | — | 137354Official source ↗ | No indexed price | — | — |
| Que Tablet 200mgRegistry verified | Quetiapine Fumarate Eq. to Quetiapine | — | — | — | 137355Official source ↗ | No indexed price | — | — |
| Que Tablet 25mgRegistry verified | Quetiapine Fumarate Eq. to Quetiapine | — | — | — | 137353Official source ↗ | No indexed price | — | — |
| Rosurot | Rosuvastatin | 5 mg | Tablet | 10's | 114652 | PKR 236.17 | PKR 23.62/tablet | No comparator |
| Rosurot | Rosuvastatin | 10 mg | Tablet | 10's | 114653 | PKR 393.61 | PKR 39.36/tablet | 🔒 Pharma Pro |
| Rosurot | Rosuvastatin | 20 mg | Tablet | 10's | 114654 | PKR 787.22 | PKR 78.72/tablet | 🔒 Pharma Pro |
| Sulmax 1g InjectionRegistry verified | Cefoperazone as sodium, Sulbactam as Sodium. | — | — | — | 013730-EXOfficial source ↗ | No indexed price | — | — |
| Sulmax 2g InjectionRegistry verified | Cefoperazone as sodium, Sulbactam as Sodium | — | — | — | 013729-EXOfficial source ↗ | No indexed price | — | — |
| Trozicine | Azithromycin | 500 mg | Tablet | 6's | 120008 | PKR 567.95 | PKR 94.66/tablet | 🔒 Pharma Pro |
| Trozicine | Azithromycin | 250 mg | Capsule | 6's | 129445 | PKR 315.99 | PKR 52.67/capsule | 🔒 Pharma Pro |
All 9 Pinnacle Biotech brands in Pakistan
- Apixion Apixaban · 2.5 mg tablet, 5 mg tablet
- Drugab Pregabalin · 100 mg capsule, 50 mg capsule, 75 mg capsule
- Empaxo Empagliflozin · 10 mg tablet, 25 mg tablet
- Empaxo-M Empagliflozin + Metformin · 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet
- Moxipill Moxifloxacin · 400 mg tablet
- Naplocip Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Pinethur Artemether · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 80 mg + 480 mg tablet
- Rosurot Rosuvastatin · 10 mg tablet, 20 mg tablet, 5 mg tablet
- Trozicine Azithromycin · 250 mg capsule, 500 mg tablet
Pinnacle Biotech: common questions
How many products does Pinnacle Biotech have in Pakistan?
Pinnacle Biotech (Pvt.) Ltd has 20 registered medicine presentations in Pakistan, sold under 9 brands and covering 9 generic medicines.
What are the main brands of Pinnacle Biotech?
By number of registered strengths and packs, its largest brands are Drugab (Pregabalin), Pinethur (Artemether), Rosurot (Rosuvastatin), Apixion (Apixaban) and Empaxo (Empagliflozin). This is not a sales ranking.
Which therapy areas does Pinnacle Biotech cover?
The most products are in Anti-infectives (8), Endocrine & metabolic (4), CNS & mental health (3), Cardiovascular (3) and Hematology & thrombosis (2).
Where can I see Pinnacle Biotech medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.